⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBX News
MBX Biosciences, Inc. Common Stock
CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
globenewswire.com
MBX
Form 8-K
sec.gov
MBX
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
globenewswire.com
MBX
Form 8-K
sec.gov
MBX
MBX Biosciences to Participate in Upcoming March Investor Conferences
globenewswire.com
MBX
MBX Biosciences to Participate in Upcoming Investor Conferences
globenewswire.com
MBX
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair
globenewswire.com
MBX
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
MBX
Toyota's next-generation navigation system is built with Mapbox
prnewswire.com
TM
MBX
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
globenewswire.com
MBX